These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19006402)

  • 1. Interplay between malaria, crystalline hemozoin formation, and antimalarial drug action and design.
    Weissbuch I; Leiserowitz L
    Chem Rev; 2008 Nov; 108(11):4899-914. PubMed ID: 19006402
    [No Abstract]   [Full Text] [Related]  

  • 2. On the kinetics of formation of hemozoin, the malaria pigment.
    Pasternack RF; Munda B; Bickford A; Gibbs EJ; Scolaro LM
    J Inorg Biochem; 2010 Oct; 104(10):1119-24. PubMed ID: 20667599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update.
    Kumar S; Guha M; Choubey V; Maity P; Bandyopadhyay U
    Life Sci; 2007 Feb; 80(9):813-28. PubMed ID: 17157328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimalarial mannoxanes: hybrid antimalarial drugs with outstanding oral activity profiles and a potential dual mechanism of action.
    Chadwick J; Amewu RK; Marti F; Garah FB; Sharma R; Berry NG; Stocks PA; Burrell-Saward H; Wittlin S; Rottmann M; Brun R; Taramelli D; Parapini S; Ward SA; O'Neill PM
    ChemMedChem; 2011 Aug; 6(8):1357-61. PubMed ID: 21692184
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemozoin biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors.
    Hempelmann E
    Parasitol Res; 2007 Mar; 100(4):671-6. PubMed ID: 17111179
    [No Abstract]   [Full Text] [Related]  

  • 6. Morphology-sensitive Raman modes of the malaria pigment hemozoin.
    Frosch T; Koncarevic S; Becker K; Popp J
    Analyst; 2009 Jun; 134(6):1126-32. PubMed ID: 19475138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel way to grow hemozoin-like crystals in vitro and its use to screen for hemozoin inhibiting antimalarial compounds.
    Thomas V; Góis A; Ritts B; Burke P; Hänscheid T; McDonnell G
    PLoS One; 2012; 7(7):e41006. PubMed ID: 22815894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution behavior of hematin under acidic conditions and implications for its interactions with chloroquine.
    Crespo MP; Tilley L; Klonis N
    J Biol Inorg Chem; 2010 Sep; 15(7):1009-22. PubMed ID: 20429019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The malarial metabolite hemozoin and its potential use as a vaccine adjuvant.
    Coban C; Yagi M; Ohata K; Igari Y; Tsukui T; Horii T; Ishii KJ; Akira S
    Allergol Int; 2010 Jun; 59(2):115-24. PubMed ID: 20414048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of chlorovinyl sulfones as structural analogs of chalcones and their antiplasmodial activities.
    Dominguez JN; Leon C; Rodrigues J; Gamboa de Dominguez N; Gut J; Rosenthal PJ
    Eur J Med Chem; 2009 Apr; 44(4):1457-62. PubMed ID: 19036479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depolymerization of malarial hemozoin: a novel reaction initiated by blood schizontocidal antimalarials.
    Pandey AV; Tekwani BL
    FEBS Lett; 1997 Feb; 402(2-3):236-40. PubMed ID: 9037202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current drug development portfolio for antimalarial therapies.
    Biagini GA; O'Neill PM; Bray PG; Ward SA
    Curr Opin Pharmacol; 2005 Oct; 5(5):473-8. PubMed ID: 16084770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of 1,1'-hydrocarbylenebis(indazol-3-ols) as potential antimalarial drugs.
    Martins Alho M; García-Sánchez RN; Nogal-Ruiz JJ; Escario JA; Gómez-Barrio A; Martínez-Fernández AR; Arán VJ
    ChemMedChem; 2009 Jan; 4(1):78-87. PubMed ID: 19025734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The malaria pigment haemozoin-a focal point of action for antimalarial drugs.
    Senge M; Hatscher S
    Chembiochem; 2000 Nov; 1(4):247-9. PubMed ID: 11828415
    [No Abstract]   [Full Text] [Related]  

  • 16. A fine balance between oxidised and reduced haem controls the survival of intraerythrocytic plasmodia.
    Taramelli D; Monti D; Basilico N; Parapini S; Omodeo-Salé F; Olliaro P
    Parassitologia; 1999 Sep; 41(1-3):205-8. PubMed ID: 10697858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimalarial drugs - what is in use and what is in the pipeline.
    Schlitzer M
    Arch Pharm (Weinheim); 2008 Mar; 341(3):149-63. PubMed ID: 18297679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The iron environment in heme and heme-antimalarial complexes of pharmacological interest.
    Adams PA; Berman PA; Egan TJ; Marsh PJ; Silver J
    J Inorg Biochem; 1996 Jul; 63(1):69-77. PubMed ID: 8699174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ localization and structural analysis of the malaria pigment hemozoin.
    Frosch T; Koncarevic S; Zedler L; Schmitt M; Schenzel K; Becker K; Popp J
    J Phys Chem B; 2007 Sep; 111(37):11047-56. PubMed ID: 17718555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A physiochemical mechanism of hemozoin (beta-hematin) synthesis by malaria parasite.
    Tripathi AK; Garg SK; Tekwani BL
    Biochem Biophys Res Commun; 2002 Jan; 290(1):595-601. PubMed ID: 11779214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.